Alder BioPharmaceuticals® Announces Second Quarter 2017 Financial and Operating Results
Aug 08, 2017 20:05 pm UTC| Business
– Positive top-line PROMISE 1 study results further support eptinezumab’s unique clinical profile – – $161.5 million from recent public offering expected to enable continued advancement of eptinezumab through pivotal...
Surgery Partners, Inc. Announces Second Quarter 2017 Results
Aug 08, 2017 20:05 pm UTC| Business
NASHVILLE, Tenn., Aug. 08, 2017 -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading provider of surgical services, today announced results for the second quarter ended June 30,...
PRA Group Reports Second Quarter 2017 Results
Aug 08, 2017 20:05 pm UTC| Business
NORFOLK, Va., Aug. 08, 2017 -- PRA Group (Nasdaq:PRAA), a global leader in acquiring and collecting nonperforming loans, today reported its financial results for the second quarter of 2017. The company reported net...
Enphase Energy Reports Financial Results for the Second Quarter of 2017
Aug 08, 2017 20:05 pm UTC| Business
PETALUMA, Calif., Aug. 08, 2017 -- Enphase Energy, Inc. (NASDAQ:ENPH), a global energy technology company and the world’s leading supplier of solar microinverters, announced today financial results for the second...
Alarm.com Reports Second Quarter 2017 Results
Aug 08, 2017 20:05 pm UTC| Business
-- SaaS and license revenue of $58.9 million, up 40% year-over-year ---- Total revenue of $86.0 million, up 33% year-over-year ---- GAAP net income of $9.9 million, compared to $1.9 million for the second quarter of 2016...
ChemoCentryx Reports Second Quarter 2017 Financial Results and Recent Highlights
Aug 08, 2017 20:05 pm UTC| Business
-- Pivotal Phase III ADVOCATE trial of avacopan on track to complete enrollment in mid-2018 as projected -- -- Launching second trial of avacopan in patients with C3 Glomerulopathy (C3G) -- -- Conference call today at...
TRACON Pharmaceuticals Reports Second Quarter Financial Results and Provides Corporate Update
Aug 08, 2017 20:05 pm UTC| Business
SAN DIEGO, Aug. 08, 2017 -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, wet age‐related...
FxWirePro- Major Economic events to watch